About us
- >
- About us >
- Information >
- Announcement
2026-02-13
Energenesis Biomedical Co., Ltd. Obtains Patent Grant in Canada for 'METHODS FOR TREATING DIABETIC ULCER' Following PCT National Phase Entry
Energenesis Biomedical Co., Ltd. has received formal notification of approval from the Canadian Patent Office for the patent application titled "METHODS FOR TREATING DIABETIC ULCER," Application No. 3212620.